Legal & General Group Plc - IMMUNITYBIO INC ownership

IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 134 filers reported holding IMMUNITYBIO INC in Q3 2023. The put-call ratio across all filers is 1.30 and the average weighting 0.0%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of IMMUNITYBIO INC
ValueSharesWeighting
Q3 2023$199,358
-39.9%
117,963
-1.2%
0.00%
Q2 2023$331,837
+228.4%
119,366
+115.0%
0.00%
Q1 2023$101,060
-55.6%
55,527
+23.8%
0.00%
Q4 2022$227,380
-0.7%
44,848
-2.4%
0.00%
Q3 2022$229,000
+45.9%
45,973
+9.4%
0.00%
Q2 2022$157,000
-12.8%
42,037
+30.8%
0.00%
Q1 2022$180,000
-4.3%
32,139
+3.8%
0.00%
Q4 2021$188,000
-37.5%
30,9760.0%0.00%
Q3 2021$301,000
+69.1%
30,976
+149.4%
0.00%
Q2 2021$178,000
-20.5%
12,421
+31.8%
0.00%
Q1 2021$224,0009,4230.00%
Other shareholders
IMMUNITYBIO INC shareholders Q3 2023
NameSharesValueWeighting ↓
Winning Points Advisors, LLC 236,956$879,0000.97%
HARBOURVEST PARTNERS LLC 335,709$1,249,0000.41%
ALLEN HOLDING INC /NY 687,571$2,558,0000.37%
MERIDIAN INVESTMENT COUNSEL INC. 96,433$359,0000.15%
SHEETS SMITH WEALTH MANAGEMENT 207,926$773,0000.13%
Corton Capital Inc. 29,032$108,0000.10%
Clearwater Capital Advisors, LLC 185,311$689,0000.09%
Delphia (USA) Inc. 31,709$118,0000.08%
Virtus ETF Advisers LLC 34,799$129,0000.05%
GSA CAPITAL PARTNERS LLP 84,884$316,0000.05%
View complete list of IMMUNITYBIO INC shareholders